5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.55▼ | 3.52▲ | 3.53▲ | 3.73▼ | 4.10▼ |
MA10 | 3.53▲ | 3.57▼ | 3.62▼ | 3.90▼ | 3.90▼ |
MA20 | 3.61▼ | 3.68▼ | 3.71▼ | 4.14▼ | 3.48▲ |
MA50 | 3.73▼ | 3.80▼ | 3.89▼ | 3.89▼ | 2.46▲ |
MA100 | 3.85▼ | 4.01▼ | 4.06▼ | 3.38▲ | 3.29▲ |
MA200 | 4.05▼ | 4.26▼ | 4.23▼ | 2.45▲ | 5.57▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | -0.010▼ | -0.014▼ | -0.094▼ | -0.001▼ |
RSI | 39.676▼ | 39.219▼ | 38.061▼ | 35.045▼ | 53.221▲ |
STOCH | 68.443 | 18.434▼ | 16.883▼ | 10.741▼ | 63.135 |
WILL %R | -69.697 | -69.697 | -75.904▼ | -93.722▼ | -67.390 |
CCI | -25.819 | -45.194 | -70.343 | -150.376▼ | -9.697 |
Thursday, April 25, 2024 01:45 PM
Recon Technology, Ltd. (NASDAQ: RCON) ("Recon" or the "Company") announced today that the Company's shareholders approved on March 29, 2024 to effect a reverse stock split of the Company's Class A ...
|
Thursday, April 25, 2024 05:01 AM
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today ...
|
Thursday, April 25, 2024 04:45 AM
Unlock the potential of adaptive immunity with ImmuneSelect by Virax Biolabs. Investigate T-Cell driven immunity for post-viral syndromes like Long COVID. Explore peptide pools and recombinant ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/04/24 | 3.69 | 3.69 | 3.45 | 3.52 | 53,002 |
24/04/24 | 3.82 | 3.90 | 3.69 | 3.75 | 21,117 |
23/04/24 | 4.13 | 4.17 | 3.77 | 3.86 | 41,466 |
22/04/24 | 3.86 | 3.86 | 3.69 | 3.74 | 54,966 |
19/04/24 | 3.78 | 4.04 | 3.76 | 3.80 | 48,572 |
18/04/24 | 3.97 | 3.97 | 3.74 | 3.83 | 85,250 |
17/04/24 | 4.05 | 4.07 | 3.92 | 3.96 | 23,740 |
16/04/24 | 4.14 | 4.183 | 4.00 | 4.04 | 25,433 |
15/04/24 | 4.36 | 4.39 | 3.98 | 4.16 | 103,802 |
12/04/24 | 4.30 | 4.36 | 4.04 | 4.32 | 221,313 |
|
|
||||
|
|
||||
|
|